|
US 12,269,801 B2 |
|
| Modified amino acids |
| Ryan Stafford, Foster City, CA (US); Christopher D. Thanos, Tiburon, CA (US); and Wenjin Yang, Foster City, CA (US) |
| Assigned to SUTRO BIOPHARMA, INC., South San Francisco, CA (US) |
| Filed by SUTRO BIOPHARMA, INC., South San Francisco, CA (US) |
| Filed on Dec. 17, 2022, as Appl. No. 18/067,709. |
| Application 15/600,632 is a division of application No. 14/015,893, filed on Aug. 30, 2013, granted, now 9,682,934, issued on Jun. 20, 2017. |
| Application 18/067,709 is a continuation of application No. 16/984,152, filed on Aug. 4, 2020, granted, now 11,548,852. |
| Application 16/984,152 is a continuation of application No. 16/173,968, filed on Oct. 29, 2018, granted, now 10,730,837, issued on Aug. 4, 2020. |
| Application 16/173,968 is a continuation of application No. 15/600,632, filed on May 19, 2017, granted, now 10,112,900, issued on Oct. 30, 2018. |
| Claims priority of provisional application 61/696,087, filed on Aug. 31, 2012. |
| Prior Publication US 2023/0139442 A1, May 4, 2023 |
| Int. Cl. C07D 213/55 (2006.01); C07C 247/04 (2006.01); C07C 271/20 (2006.01); C07C 275/14 (2006.01); C07K 14/00 (2006.01); C07K 16/00 (2006.01) |
